Evidence map›Paper›PMID 35143571›Full record

ArticlePloS one2022

Detailed analysis of the pathologic hallmarks of Nipah virus (Malaysia) disease in the African green monkey infected by the intratracheal route.

Curtis Cline, Todd M Bell, Paul Facemire, Xiankun Zeng, Thomas Briese, W Ian Lipkin, Joshua D Shamblin, Heather L Esham, Ginger C Donnelly, Joshua C Johnson and 3 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.9field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 7 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 5 institutions in 1 country.

Curtis ClinePathology Division, United States Army Medical Research Institute of Infectious Diseases, Fort Detrick, Maryland, United States of America.ORCID 0000-0003-2603-8237
Todd M BellPathology Division, United States Army Medical Research Institute of Infectious Diseases, Fort Detrick, Maryland, United States of America.
Paul FacemirePathology Division, United States Army Medical Research Institute of Infectious Diseases, Fort Detrick, Maryland, United States of America.
Xiankun ZengPathology Division, United States Army Medical Research Institute of Infectious Diseases, Fort Detrick, Maryland, United States of America.
Thomas BrieseCenter for Infection and Immunity, Columbia University Mailman School of Public Health, New York, New York, United States of America.
W Ian LipkinCenter for Infection and Immunity, Columbia University Mailman School of Public Health, New York, New York, United States of America.
Joshua D ShamblinVeterinary Medicine Division, United States Army Medical Research Institute of Infectious Diseases, Fort Detrick, Maryland, United States of America.
Heather L EshamVeterinary Medicine Division, United States Army Medical Research Institute of Infectious Diseases, Fort Detrick, Maryland, United States of America.
Ginger C DonnellyVirology Division, United States Army Medical Research Institute of Infectious Diseases, Fort Detrick, Maryland, United States of America.
Joshua C JohnsonInfectious Disease Research Portfolio, Strategy & Operations, Moderna, Boston, Massachusetts, United States of America.
Lisa E HensleyOffice of the Chief Scientist, National Institute of Allergy and Infectious Disease Integrated Research Facility, Fort Detrick, Maryland, United States of America.
Anna N HonkoNonclinical Studies Unit, Boston University School of Medicine National Emerging Infectious Diseases Laboratories, Boston, Massachusetts, United States of America.ORCID 0000-0001-9165-148X
Sara C JohnstonVirology Division, United States Army Medical Research Institute of Infectious Diseases, Fort Detrick, Maryland, United States of America.
United States Army Medical Research Institute of Infectious Diseases · USColumbia University · USBoston University · USModerna Therapeutics (United States) · USNational Institute of Allergy and Infectious Diseases · US

Funding

Viral Pathogenesis and TherapeuticsU54AI057158 · NIAID · WADSWORTH CENTER · PI LEVY, DAVID E · 2003 to 2014
$100.8M
NIAID NIH HHS U54 AI057158
6 · The paper itself

Abstract

Disease associated with Nipah virus infection causes a devastating and often fatal spectrum of syndromes predominated by both respiratory and neurologic conditions. Additionally, neurologic sequelae may manifest months to years later after virus exposure or apparent recovery. In the two decades since this disease emerged, much work has been completed in an attempt to understand the pathogenesis and facilitate development of medical countermeasures. Here we provide detailed organ system-specific pathologic findings following exposure of four African green monkeys to 2.41×105 pfu of the Malaysian strain of Nipah virus. Our results further substantiate the African green monkey as a model of human Nipah virus disease, by demonstrating both the respiratory and neurologic components of disease. Additionally, we demonstrate that a chronic phase of disease exists in this model, that may provide an important opportunity to study the enigmatic late onset and relapse encephalitis as it is described in human disease.

Indexed as

AnimalsChlorocebus aethiopsDisease Models, AnimalEncephalitis, ViralHenipavirus InfectionsLung DiseasesMalaysiaMaleNipah Virus

Identifiers

PMID35143571
PMCPMC8830707
OpenAlexW4211115614

What OpenQuestion holds

Textmetadata
LicenceCC0
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.